Matinas BioPharma Holdings Inc (NYSE American:MTNB)

0.6821
Delayed Data
As of May 13
 +0.0115 / +1.71%
Today’s Change
0.49
Today|||52-Week Range
1.61
-32.47%
Year-to-Date

Today’s Trading

Previous close0.67
Today’s open0.66
Day’s range0.65 - 0.70
Volume810,858
Average volume (3 months)720,769
Market cap$148.8M
Data as of 3:39pm ET, 05/13/2022

Growth & Valuation

Earnings growth (last year)+4.49%
Earnings growth (this year)-18.18%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.95%
P/E ratioNM
Price/Sales6,368.47
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
FENCFennec Pharmaceutica...+0.22+4.15%
CNCEConcert Pharmaceutic...+0.50+14.49%
SLGLSol Gel Technologies...+0.35+6.00%
SVRASavara Inc+0.11+9.65%
Data as of 4:00pm ET, 05/13/2022

Financials

Next reporting dateAugust 9, 2022
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$33.3K
Annual profit (last year)-$23.3M
Net profit margin-69,850.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Bedminster, New Jersey

Forecasts